Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inari Medical, Inc. stock logo
NARI
Inari Medical
$79.97
$79.97
$39.76
$79.99
$4.68B1.021.34 million shsN/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$28.96
+0.5%
$27.48
$23.69
$31.72
$12.68B0.68793,470 shs459,042 shs
Solventum Co. stock logo
SOLV
Solventum
$73.04
+0.6%
$69.45
$47.16
$85.92
$12.64BN/A1.25 million shs4.07 million shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$92.12
-1.3%
$99.99
$89.92
$116.71
$18.23B0.781.81 million shs3.51 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inari Medical, Inc. stock logo
NARI
Inari Medical
0.00%0.00%0.00%0.00%+60.20%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
+0.44%+1.08%+3.43%-0.05%+16.40%
Solventum Co. stock logo
SOLV
Solventum
+0.68%+3.09%+10.38%-8.19%+22.30%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
-1.24%-0.78%-10.62%-11.69%-19.99%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.1412 of 5 stars
1.03.02.50.02.60.03.1
Solventum Co. stock logo
SOLV
Solventum
0.5377 of 5 stars
1.13.00.00.03.60.00.0
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.9369 of 5 stars
3.15.02.53.73.42.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inari Medical, Inc. stock logo
NARI
Inari Medical
2.14
Hold$69.22-13.44% Downside
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.00
Hold$28.00-3.31% Downside
Solventum Co. stock logo
SOLV
Solventum
2.10
Hold$80.299.92% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.29
Hold$111.5321.07% Upside

Current Analyst Ratings Breakdown

Latest NARI, ZBH, SNN, and SOLV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Solventum Co. stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$78.00 ➝ $87.00
5/12/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$115.00 ➝ $101.00
5/9/2025
Solventum Co. stock logo
SOLV
Solventum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$80.00 ➝ $78.00
5/7/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$140.00 ➝ $125.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$101.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$138.00 ➝ $115.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$120.00 ➝ $104.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$119.00 ➝ $104.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$125.00 ➝ $112.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$115.00 ➝ $95.00
5/6/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$128.00 ➝ $105.00
(Data available from 5/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inari Medical, Inc. stock logo
NARI
Inari Medical
$493.63M9.48$0.09 per share906.95$8.07 per share9.91
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$5.81B2.18$3.62 per share8.00$11.94 per share2.43
Solventum Co. stock logo
SOLV
Solventum
$8.31B1.52N/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.70B2.37$11.74 per share7.85$62.67 per share1.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inari Medical, Inc. stock logo
NARI
Inari Medical
-$1.64M-$1.35N/A727.00N/A-13.68%-10.09%-6.60%N/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$263M$2.1613.4114.481.26N/AN/AN/A8/5/2025 (Estimated)
Solventum Co. stock logo
SOLV
Solventum
N/A$2.1633.8113.301.94N/AN/AN/A8/14/2025 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.5220.7010.391.9511.77%12.99%7.58%8/6/2025 (Estimated)

Latest NARI, ZBH, SNN, and SOLV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Solventum Co. stock logo
SOLV
Solventum
$1.19$1.34+$0.15$0.78$2.02 billion$2.07 billion
5/5/2025Q1 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.77$1.81+$0.04$0.91$1.89 billion$1.91 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/AN/AN/AN/AN/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$0.893.07%N/A41.20%N/A
Solventum Co. stock logo
SOLV
Solventum
N/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.961.04%N/A21.24%N/A

Latest NARI, ZBH, SNN, and SOLV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/30/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.241.03%6/26/20257/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inari Medical, Inc. stock logo
NARI
Inari Medical
N/A
1.77
1.40
Smith & Nephew plc stock logo
SNN
Smith & Nephew
0.63
2.51
1.11
Solventum Co. stock logo
SOLV
Solventum
2.45
1.15
0.83
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.43
1.91
0.99

Institutional Ownership

CompanyInstitutional Ownership
Inari Medical, Inc. stock logo
NARI
Inari Medical
90.98%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
25.64%
Solventum Co. stock logo
SOLV
Solventum
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Inari Medical, Inc. stock logo
NARI
Inari Medical
10.60%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
1.00%
Solventum Co. stock logo
SOLV
Solventum
0.05%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inari Medical, Inc. stock logo
NARI
Inari Medical
80058.54 million52.34 millionOptionable
Smith & Nephew plc stock logo
SNN
Smith & Nephew
20,100437.96 million432.83 millionOptionable
Solventum Co. stock logo
SOLV
Solventum
22,000173.01 millionN/AOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
18,000197.85 million197.18 millionOptionable

Recent News About These Companies

Zacks Research Forecasts Lower Earnings for Zimmer Biomet
Zacks Research Expects Reduced Earnings for Zimmer Biomet
Zimmer Biomet in 2025: 10 updates

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Inari Medical stock logo

Inari Medical NASDAQ:NARI

$79.97 0.00 (0.00%)
As of 02/19/2025

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Smith & Nephew stock logo

Smith & Nephew NYSE:SNN

$28.96 +0.14 (+0.49%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$28.96 -0.01 (-0.02%)
As of 05/30/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Solventum stock logo

Solventum NYSE:SOLV

$73.04 +0.43 (+0.59%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$73.09 +0.05 (+0.07%)
As of 05/30/2025 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$92.12 -1.22 (-1.31%)
Closing price 05/30/2025 03:59 PM Eastern
Extended Trading
$92.17 +0.05 (+0.05%)
As of 05/30/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.